Paul W. Hawran, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 20,000 shares at $4.24 ($85K) on 2009-11-18, disclosed to the SEC on 2009-11-18.
Open-market purchase of $85k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.24 | 10,000 | $42K | 49.9% |
| 2 | $4.25 | 10,000 | $43K | 50.1% |
| Total | $4.25 avg | 20,000 | $85K | 100% |
| Filing → |
| CYTX | BUY | 2010-05-19 | $24K | — | Filing → |
| CYTX | BUY | 2009-11-25 | $25K | — | Filing → |
| CYTX | BUY | 2009-11-24 | $24K | — | Filing → |